Header Logo

Connection

Peter Heydemann to Disease Progression

Back to Details
This is a "connection" page, showing publications Peter Heydemann has written about Disease Progression.
Peter Heydemann
Connection Strength
0.159
Disease Progression
  1. A Combined Prospective and Retrospective Comparison of Long-Term Functional Outcomes Suggests Delayed Loss of Ambulation and Pulmonary Decline with Long-Term Eteplirsen Treatment. J Neuromuscul Dis. 2022; 9(1):39-52.
    View in: PubMed
    Score: 0.159
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.